Publicaciones (63) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. Fluoxetine oral treatment discloses 5-HT 1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat

    Canadian Journal of Physiology and Pharmacology, Vol. 97, Núm. 2, pp. 90-98

  2. Hypertension exhibits 5-HT 4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature

    Hypertension Research, Vol. 42, Núm. 5, pp. 618-627

  3. Angiogenic response in an in vitro model of dog microvascular endothelial cells stimulated with antigenic extracts from Dirofilaria immitis adult worms

    Parasites and Vectors, Vol. 12, Núm. 1

  4. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses

    The Lancet, Vol. 393, Núm. 10174, pp. 899-909

  5. Asthma diagnosis in infants and preschool children: a systematic review of clinical guidelines

    Allergologia et Immunopathologia, Vol. 47, Núm. 2, pp. 107-121

  6. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I/II clinical trial with long-term follow-up

    Stem Cell Research and Therapy, Vol. 10, Núm. 1

  7. Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition

    Scientific Reports, Vol. 9, Núm. 1

  8. Biopiracy versus One-World Medicine–From colonial relicts to global collaborative concepts

    Phytomedicine, Vol. 53, pp. 319-331

  9. Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease

    Acta Physiologica, Vol. 226, Núm. 2

  10. Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy

    Hepatology, Vol. 70, Núm. 4, pp. 1246-1261

  11. Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps

    Archives of Toxicology, Vol. 93, Núm. 3, pp. 623-634

  12. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  13. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

    British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104

  14. Development and characterization of mouse monoclonal antibodies to eight human complement components: Analysis of reactivity with orthologs of nine mammalian genera

    Comparative Immunology, Microbiology and Infectious Diseases, Vol. 62, pp. 7-12

  15. Diagnostic and prognostic biomarkers in cholangiocarcinoma

    Liver International, Vol. 39, Núm. S1, pp. 108-122

  16. Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: Potential antitumour dual agents

    MedChemComm, Vol. 10, Núm. 9, pp. 1589-1598

  17. Dirofilaria immitis: A new potential pathogen for the endangered iberian lynx (Lynx pardinus)

    International Journal of Applied Research in Veterinary Medicine, Vol. 17, Núm. 1, pp. 17-21

  18. Dispositivos de inhalación en medicación inhalada

    Protocolo diagnostico terapéutico pediatría, Vol. 2, pp. 51-64

  19. Dual RNA-seq analysis provides new insights into interactions between Norway spruce and necrotrophic pathogen Heterobasidion annosum s.l.

    BMC Plant Biology, Vol. 19, Núm. 1

  20. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800